The S&P 500 (SPY) has made great advances since the lows of early April. Yet seem to be stuck under resistance at 6,000. What ...

The phrase that paid for investors in 2025 was “Bull market til proven otherwise” Steve Reitmeister explains why in his ...

We spent the last few weeks contemplating what it means for the S&P 500 (SPY) to break below the 200 day moving average. The good news is that it rarely becomes a bear market. The bad news is that ...

The S&P 500 (SPY) is now exploring new heights above 6,000. But not everything is rainbows and lollipops. Unfortunately, market breadth has narrowed once again with investors pressing the “Easy Button ...

My monthly webinar for the Zen Investor service is set for Wednesday afternoon. The focus of that presentation is whether the election of Donald Trump changes my stock market outlook. I thought that ...

In the famed Stock Traders Almanac, author Jeffrey Hirsch shares statistics on how September is the worst month of the year for stocks. Investment commentators love to site these facts to get people ...

The traditional investment media has a bad habit. Each and every day they want to write articles that have a cause and effect. As in “the market was down today because of reason X”. And the next day ...

One of the screens we use in the POWR Options trade selection process involves comparing recent performance to help identify relative underperformance in Strong Buy (A – Rated) stocks. The expectation ...

GameStop Corp. (GME), a leading retailer of video game hardware and software products, is scheduled to deliver its fourth-quarter and full-year earnings report on Tuesday, March 26, 2024, after the ...

TXT – With escalating geopolitical instability driving the spending levels of economies, backed by rapid technological adoption among industry players, the air defense industry’s prospects appear ...

The pharmaceutical industry continues to witness steady growth and expansion owing to the rising adoption of biologics, increasing demand for personalized medicine, and consistent research and ...

In an update, pharmaceutical multinational Merck & Co., Inc. (MRK) projected an upward revision in its annual sales forecast- a range of $59.7 billion to $60.2 billion as compared to the earlier ...